Chinese Validation of the Simplified Evaluation of CONsciousness Disorders(SECONDs)

NCT ID: NCT05496985

Last Updated: 2022-08-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

49 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-12-20

Study Completion Date

2022-03-14

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study was to translate the SECONDs from French into Chinese and assess the validity and reliability of the Chinese version of the SECONDs .

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To promote accurate assessments of DoC patients and the development of clinical research on DoC in China, we here propose and validate a version of the SECONDs translated into Mandarin Chinese. Hence, this study aims to assess the concurrent validity (compared with the CRS-R which has already been translated and validated in Mandarin), intra-rater reliability, and inter-rater reliability of the Chinese version of the SECONDs

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Brain Diseases Vegetative State Unconsciousness Central Nervous System Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Each patient was assessed by three distinct assessors who were experienced and trained to use the CRS-R. All assessments were completed within two weeks (i.e., five CRS-R to obtain a reliable diagnosis \[17\], and 7 SECONDs performed by 3 different assessors in the 2 weeks) in five different sessions. Session 1 included one evaluation with the CRS-R performed by one assessor (i.e., concurrent validity) and three evaluations with the SECONDs performed by two assessors (i.e., intra-rater reliability and inter-rater reliability). The other sessions (2 to 5) each included one evaluation with the SECONDs and one evaluation with the CRS-R (i.e., concurrent validity) performed by two assessors. Each SECONDs was performed alternatively either before or after the CRS-R assessment. To avoid fatigue effects and reduce the impact of within-day fluctuations of vigilance, a break of 30 to 80 min between each assessment was taken.
Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

SINGLE

Outcome Assessors
Until the end of the protocol, all three assessors were blinded to the scores acquired by the other assessors.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients in coma

Patients in coma were assessed by the SECONDs and CRS-R for five days.

Group Type EXPERIMENTAL

Simplified Evaluation of CONsciousness Disorders (SECONDs)

Intervention Type DIAGNOSTIC_TEST

All patients were assessed by the Simplified Evaluation of CONsciousness Disorders (SECONDs) and Coma Recovery Scale-Revised (CRS-R)

Patients in unresponsive wakefulness syndrome

Patients in unresponsive wakefulness syndrome were assessed by the SECONDs and CRS-R for five days.

Group Type EXPERIMENTAL

Simplified Evaluation of CONsciousness Disorders (SECONDs)

Intervention Type DIAGNOSTIC_TEST

All patients were assessed by the Simplified Evaluation of CONsciousness Disorders (SECONDs) and Coma Recovery Scale-Revised (CRS-R)

Patients in minimally conscious state

Patients in minimally conscious state were assessed by the SECONDs and CRS-R for five days.

Group Type EXPERIMENTAL

Simplified Evaluation of CONsciousness Disorders (SECONDs)

Intervention Type DIAGNOSTIC_TEST

All patients were assessed by the Simplified Evaluation of CONsciousness Disorders (SECONDs) and Coma Recovery Scale-Revised (CRS-R)

Patients in emerge from the minimally conscious state

Patients in emerge from the minimally conscious state were assessed by the SECONDs and CRS-R for five days.

Group Type EXPERIMENTAL

Simplified Evaluation of CONsciousness Disorders (SECONDs)

Intervention Type DIAGNOSTIC_TEST

All patients were assessed by the Simplified Evaluation of CONsciousness Disorders (SECONDs) and Coma Recovery Scale-Revised (CRS-R)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Simplified Evaluation of CONsciousness Disorders (SECONDs)

All patients were assessed by the Simplified Evaluation of CONsciousness Disorders (SECONDs) and Coma Recovery Scale-Revised (CRS-R)

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Acute (longer than 14 days, less than 28 days) or prolonged DoC (following severe acquired brain injury, longer than 28 days);
* Age: 18-85 years old;
* No history of other neurological or psychiatric deficits;
* Ability to speak Chinese fluently;
* Medical stability (e.g., absence of mechanical ventilation, sedation, infection)

Exclusion Criteria

* None
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hangzhou Normal University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Haibo Di

professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Haibo Di

Role: STUDY_DIRECTOR

International Vegetative State and Consciousness Science Institute,Hangzhou Normal University

Anqi Wang

Role: PRINCIPAL_INVESTIGATOR

International Vegetative State and Consciousness Science Institute,Hangzhou Normal University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

International Vegetative State and Consciousness Science Institute, Hangzhou Normal University

Hangzhou, Zhejiang, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

YCYY-20211021-003

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.